Free tool
Oncology stocks
We cover 3 companies grouped under the Oncology theme. The median market value in the group is $1.14B. Across the group, the median move over the past trading day is −0.09%. Price change over the past year runs from −20.2% to +45.2% across the middle 80 percent of the group, with a median of +8.4%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
3 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.39B | Mid cap | +54.43% | Oct 29, 2026 |
| 2160.T | GNI Group Ltd. | $1.14B | Small cap | +8.36% | Nov 13, 2026 |
| 4587.T | PeptiDream Inc. | $891.51M | Small cap | −27.31% | Nov 11, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.